Xenon Pharmaceuticals Inc (XENE)
Operating Income Growth
-30.70%
Quarterly · Period ending:
XENE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.70%period ending
Latest reported-30.70%period ending
XENE Quarterly Operating Income YoY % (530.01% → -30.70%)
Year-over-year change
High-resolution chart · PNG
XENE operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -30.6976% | |
| -54.4282% | |
| -41.6769% | |
| -30.7563% | |
| -36.3582% | |
| -23.1991% | |
| -44.2909% | |
| -32.3109% | |
| -24.2341% | |
| -20.3666% | |
| -23.9182% | |
| -46.0449% | |
| -83.4867% | |
| -182.4054% | |
| -74.4545% | |
| -144.4416% | |
| -34.7453% | |
| -8.1574% | |
| -92.2% | |
| -60.8207% | |
| -3,382.6625% | |
| -99.9129% | |
| -11.4244% | |
| -8.3566% | |
| 93.8546% | |
| 31.6806% | |
| -37.5148% | |
| 36.867% | |
| -38.5711% | |
| -50.3965% | |
| -4.7572% | |
| -64.0213% | |
| 3.8895% | |
| 2.1159% | |
| -47.4002% | |
| -17.9102% | |
| -23.9868% | |
| -41.163% | |
| -109.8348% | |
| -794.0244% | |
| -3,298.995% | |
| -369.1542% | |
| -7,537.1429% | |
| -109.4677% | |
| -85.5588% | |
| -216.8605% | |
| -98.2665% | |
| 32.8578% | |
| 134.753% | |
| 75.8092% | |
| 233.1794% | |
| 530.0132% |